BioMedTech Incubator
Supports incubator organisations enabling early-stage translation and commercialisation of biomedical innovations.
The 2026 BioMedTech Incubator is a grant opportunity funded through the Australian Government's Medical Research Future Fund (MRFF) Medical Research Commercialisation Initiative, which has allocated A$450 million over ten years from 2024-25 to 2033-34. The BioMedTech Incubator sub-program provides up to A$33 million per awarded incubator organisation to support early-stage translation and commercialisation of biomedical and health technology innovations, with a focus on Australian small and medium enterprises. The program is delivered externally by MTPConnect, a not-for-profit medical technology industry body, rather than directly by the Department of Health, Disability and Ageing.
Applications are open to Australian-based organisations — including for-profits, nonprofits, universities, and research organisations — that can credibly operate as incubators for biomedical or health technology SMEs. Individuals are ineligible. The predecessor sub-programs (BioMedTech Horizons and Biomedical Translation Bridge) are explicitly closed for new funding; this 2026 round continues the incubator stream with a fresh A$99 million tranche covering three years from 2024-25. Applications are submitted via GrantConnect (grants.gov.au), not through DoHDA directly. The MRFF general enquiries contact is MRFF@health.gov.au, and MTPConnect can be reached at 03 9070 8298.
Organisations best positioned to win this grant are those with established networks in the Australian biomedical and health technology ecosystem, a demonstrable track record supporting SME translation and commercialisation, and the administrative capacity to manage grants of up to A$33 million. The 2026 round sits within Australia's broader MRFF 3rd 10-year Investment Plan (A$6.5 billion, 2024-25 to 2033-34), giving awarded incubators multi-year visibility into the government's commercialisation priorities.
Funds incubator organisations to support early-stage translation and commercialisation of biomedical and health technology innovations for Australian SMEs, with up to A$33 million per incubator.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see the timeline